AA |
Arachidonic acid |
ACTH |
Adrenocorticotropic hormone |
AEA |
Anandamide |
ASD |
Autism spectrum disorders |
Bdnf |
Brain derived neurotrophic factor |
BMA |
Basomedial nucleus of the amygdala |
BLA |
Basolateral nucleus of the amygdala |
CB1-R |
Cannabinoid type 1 receptor |
CeA |
Central nucleus of the amygdala |
CeM |
Centromedial nucleus of the amygdala |
CORT |
Corticosterone |
CRS |
Chronic restraint stress |
CRF |
Corticotrophin releasing factor |
CSDS |
Chronic social defeat stress |
CUS |
Chronic unpredictable stress |
Dnmt |
DNA methyltransferase |
eCB |
Endocannabinoid |
FAAH |
Fatty acid amine hydrolase |
GAD67 |
Glutamic acid decarboxylase enzime, 67KDa |
GR |
Gucocorticoid receptor |
HPA |
Hypothalamic pituitary adrenal |
LA |
Lateral nucleus of the amygdala |
MeA |
Medial nucleus of the amygdala |
NR-1 |
Subunit 1 of the N-Metyl-D-Aspartate (NMDA) receptor |
OXTR |
Oxytocin receptor |
POMC |
Proopiomelano-cortin |
PSA-NCAM |
Polysialylated form of the neural cell adhesion molecule (NCAM) |
PTSD |
Post-traumatic stress disorder |
PV |
Parvalbumin |
PWSI |
Post-weaning social isolation |
RORA |
RAR related orphan receptor A (circadian rhythm-related gene) |
UCMS |
Unpredictable chronic mild stress |
VGAT |
Vesicular GABA transporter |
VGLUT1 |
Vesicular glutamate transporter type 1 |
WHO |
World Health Organization |
2-AG |
2-arachidonoyl-glycerol |
Δ9-THC |
Δ9-Tetrahydrocannabinol |